MARKET

ENZ

ENZ

Enzo Biochem Inc
NYSE
1.040
-0.020
-1.89%
Opening 15:43 04/25 EDT
OPEN
1.060
PREV CLOSE
1.060
HIGH
1.063
LOW
1.040
VOLUME
50.42K
TURNOVER
0
52 WEEK HIGH
2.740
52 WEEK LOW
1.040
MARKET CAP
53.27M
P/E (TTM)
-2.0804
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ENZ last week (0415-0419)?
Weekly Report · 3d ago
Weekly Report: what happened at ENZ last week (0408-0412)?
Weekly Report · 04/15 09:26
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
PriceSmart, Inc. Posted better-than-expected earnings for its second quarter. The company reported quarterly sales of $1.29 billion. PriceSmart shares surged 4.6% to $86.90 in pre-market trading. Marin Software Incorporated shares rose 76.1% after the company announced upgrades to its Microsoft Corp advertising integration.
Benzinga · 04/10 12:12
Weekly Report: what happened at ENZ last week (0401-0405)?
Weekly Report · 04/08 09:28
Weekly Report: what happened at ENZ last week (0325-0329)?
Weekly Report · 04/01 09:28
Weekly Report: what happened at ENZ last week (0318-0322)?
Weekly Report · 03/25 09:29
Weekly Report: what happened at ENZ last week (0311-0315)?
Weekly Report · 03/18 09:28
Enzo Biochem Non-GAAP EPS of $0.00, revenue of $8.55M
Seeking Alpha · 03/13 20:54
More
About ENZ
Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The Company is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. The Company's products and technologies are used in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. Its life science division supports the work of research centers and industry partners. It has built a portfolio of intellectual property assets, comprised of around 457 owned patents worldwide.

Webull offers Enzo Biochem Inc stock information, including NYSE: ENZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENZ stock methods without spending real money on the virtual paper trading platform.